In his grandmother’s house in Kennedy, 3-year-old Wyatt Medlen races from room to room, a bundle of chatter about tools, motorcycles and mowing the lawn with his papa.
At one point, he shouts out from the kitchen to ask his mother, Patricia Medlen, whether he can have a cookie.
“There’s three carbs in seven cookies,” Wyatt’s mom tells his grandmother. “He can have one.”
For Wyatt, a severe restriction of carbs is the primary treatment for a nearly 18-month-long medical mystery that finally resulted in a diagnosis of Pyruvate Dehydrogenase Complex Deficiency, or PDCD, a rare metabolic disease predominantly affecting children.
While the first case of the disease was discovered more than 50 years ago, it is still relatively unknown.
A group of parents, including Medlen, hopes to change that through a foundation created in November. Separately, a UPMC Children’s Hospital of Pittsburgh physician and researcher is working to implement newborn screening for PDCD, in an effort to start children on the carb-restricted diet or other treatment before the disease does permanent damage.

“It is the second most common mitochondrial disease, and it has the largest patient population, but you will never hear of it,” said Medlen, of Peters. “And that's kind of like what we're trying to fix.”
For Wyatt, who will turn 4 next month, the first sign of PDCD came when he was almost 2 years old.
The family went on a trip to Florida and stopped to spend the night in a hotel in Georgia on the way home. When Wyatt woke up the next morning, he could barely walk.
“His legs were like spaghetti noodles,” said his mom. He tried to walk from the hotel room to the elevator and couldn’t take a step or two without falling.
Wyatt then began vomiting, and the Medlens drove straight from Georgia to his pediatrician, who thought it could be a post-viral syndrome brought on by a recent bout of croup. To investigate further, they took him to UPMC Children’s Hospital of Pittsburgh, luggage still in their car. An MRI revealed a set of lesions on the globus pallidus section of Wyatt’s brain, which affects movement.
The finding was unusual, to say the least. “We had about 10 neurologists come in every single time,” said Medlen. “I'm talking like the whole group, it was insane — filled the room observing him.”
Due to the location of the lesions, doctors ordered genetic tests, which determined that Wyatt had a mutation on his PDHA1 gene, but that his specific mutation hadn’t been reported previously in scientific literature.
Wyatt stayed at Children’s for over a week, spending his second birthday in the hospital. He was sent home after his walking improved with a massive dose of steroids, only to lose leg function again four days later and return to the hospital.
At that point, a test revealed that his body had almost no vitamin B1, also known as thiamine. Because thiamine is present in foods such as bread and cereal, a deficiency in a child is rare.
Doctors immediately started Wyatt on an IV of vitamin B1. “And lo and behold, it cured him,” said his mom. “It was amazing. After like one day, he could walk again.”
Wyatt’s walking was largely restored, but because Wyatt’s particular mutation hadn’t been seen before in scientific literature, the actual diagnosis for the cause of his symptoms took longer. In November, almost a year and a half after his first visit to the hospital, Wyatt received the diagnosis of PDCD.

People with PDCD have trouble metabolizing carbohydrates to turn them into energy because their bodies cannot break down a byproduct called pyruvate. The excess pyruvate turns into lactic acid, which can cause permanent damage to their brains and other organs.
Thiamine can also help to break down pyruvate, and people with PDCD sometimes use up all their thiamine to do so — leading to a deficiency there as well.
PDCD affects approximately 1 in 40,000 people. About 40% of children with PDCD die before they turn 3 months old, 60% die before 1 year old and 90% die before the age of 4. Children who are diagnosed with PDCD later in childhood, such as Wyatt, tend to have a milder form of the disease.
While a low carb, ketogenic diet can’t cure the disease, it can dramatically slow its progression.
For that reason, time is of the essence when it comes to identifying and treating PDCD, said Jirair Krikor Bedoyan, an associate professor of pediatrics at the University of Pittsburgh School of Medicine in the Division of Genetic and Genomic Medicine and one of the leading experts on PDCD.
“Identifying these kids early is important because there are ways to mitigate some of the clinical consequences of this disorder,” he said. “Unfortunately, the mean and median ages of diagnoses as published is 12 months and 31 months. It’s taking a while to identify these kids.”
Bedoyan has a medical degree and a Ph.D. and sees patients — including Wyatt — at UPMC Children’s Hospital. He received a federal grant to implement a study adding PDCD to Ohio’s newborn screening program when he worked in Cleveland.
The newborn screen was able to genetically identify several children in Ohio with the disease and to start them on a carb-free diet from birth, and Bedoyan still treats some of them.
“Studies report that 90% of them would die by 4 years old, but that’s not the case now that they start with a ketogenic diet,” he said. “We are seeing they live longer and have a better quality of life.”
Bedoyan is currently trying to expand the newborn screening pilot to Pennsylvania, where estimates that three babies with PDCD are born every year. In March, he presented the case for adding PCDC to the state’s newborn screening technical advisory board.
Bedoyan and other scientists are also researching small molecule therapy that could potentially cure some percentage of PDCD cases, similar to how a small molecule application was effective for cystic fibrosis, he said.
Families affected by PDCD started the Hope for PDCD Foundation in November to try to raise awareness of the disease and push for scientific advances.
One of their goals is to create a standard of care so that hospitals know the protocols for treating children with PDCD — not using IVs with a sugar solution, for example.
The group is also raising money to fund a gene therapy study at the University of Texas Southwestern Hospital. They have raised more than $400,000 toward their initial goal of $500,000 to fund a phase 1 mice study.
Part of that money was raised in honor of Wyatt, who threw out the first pitch last month at the Washington Wild Things game as part of a “Pitch for PDCD” fundraiser.
Through donations from companies and individuals, the Medlen family raised more than $20,000 for the foundation as part of the event, which included a John Deere-sponsored concert by Wyatt’s favorite singer, Nashville-based Davis Loose. Wyatt, a lover of all things lawn care-related, discovered the YouTube video for Loose’s song, “John Deere Tractor Beer” and quickly became obsessed.

As part of the genetic testing, Wyatt’s mom found out that she, too, has a mutation on her PDHA1 gene, meaning that she also likely has a mild form of PDCD. The finding explains some lifelong health issues, she said, such as a lack of reflexes in her legs, diminished sensation in some parts of her body and childhood clumsiness. She now takes a large dose of thiamine.
A scan in March revealed that Wyatt has developed a second brain lesion, and he still falls sometimes, particularly when tired or sick. But the family hopes that with his new carb-restricted diet, the progression of the disease will slow considerably.
The best guess for a prognosis, said Medlen, is that while he may eventually need a wheelchair, there’s a good chance he can live a productive life in adulthood.
She wonders, though, what his life could be like if the disease were more well known, and if his case was caught earlier and he was put on the low carb diet before the brain lesions formed.
“The newborn screening, I feel it could have saved Wyatt,” she said, “and it could save so many more kids.”
Anya Sostek: asostek@post-gazette.com





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.